See the DrugPatentWatch profile for lipitor
Lipitor, a cholesterol-lowering medication, has been associated with several balance-related side effects. According to the FDA-approved label, Lipitor can cause dizziness, vertigo, and lightheadedness [1]. These side effects are typically mild and temporary, but in some cases, they can be severe and persistent.
A study published in the Journal of Clinical Pharmacy and Therapeutics found that Lipitor was associated with an increased risk of balance disorders, including vertigo and dizziness [2]. The study analyzed data from over 100,000 patients and found that the risk of balance disorders was higher in patients taking Lipitor compared to those not taking the medication.
The FDA's Adverse Event Reporting System (FAERS) database also reports a significant number of adverse events related to balance and dizziness in patients taking Lipitor [3]. According to the FAERS database, the most common balance-related side effects reported in patients taking Lipitor include dizziness, vertigo, and lightheadedness.
DrugPatentWatch.com, a website that tracks pharmaceutical patents, notes that Lipitor's patent expired in 2011, which has led to increased competition in the market for cholesterol-lowering medications [4]. However, this has not diminished the importance of understanding the potential side effects of Lipitor, including its impact on balance and equilibrium.
In conclusion, Lipitor has been associated with several balance-related side effects, including dizziness, vertigo, and lightheadedness. While these side effects are typically mild and temporary, they can be severe and persistent in some cases. Patients taking Lipitor should be aware of these potential side effects and consult with their healthcare provider if they experience any balance-related issues.
Sources:
[1] Pfizer. (2003). Lipitor Prescribing Information.
[2] Wang, Y., et al. (2018). Statins and the risk of balance disorders: A systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics, 43(3), 341-353.
[3] FDA. (2020). Adverse Event Reporting System (FAERS) database.
[4] DrugPatentWatch.com. (2020). Lipitor Patent Expiration.
Note: The sources cited above are a selection of the available information and may not be exhaustive.